Texas Yale Capital Corp’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Buy
11,316
+5,180
+84% +$1.43M 0.05% 184
2026
Q1
$1.81M Hold
6,136
0.05% 211
2025
Q4
$1.68M Hold
6,136
0.05% 223
2025
Q3
$1.66M Hold
6,136
0.05% 216
2025
Q2
$1.69M Hold
6,136
0.06% 203
2025
Q1
$1.63M Hold
6,136
0.07% 206
2024
Q4
$1.42M Hold
6,136
0.06% 218
2024
Q3
$1.35M Hold
6,136
0.06% 227
2024
Q2
$1.21M Hold
6,136
0.06% 228
2024
Q1
$1.32M Hold
6,136
0.06% 225
2023
Q4
$1.29M Hold
6,136
0.06% 217
2023
Q3
$1.23M Sell
6,136
-200
-3% -$39.8K 0.06% 205
2023
Q2
$1.17M Hold
6,336
0.06% 221
2023
Q1
$1.21M Hold
6,336
0.06% 221
2022
Q4
$1.07M Hold
6,336
0.06% 234
2022
Q3
$1.12M Buy
+6,336
New +$1.25M 0.07% 213

Other funds holding CME

Texas Yale Capital Corp's CME Position: Q2 2026 in Review

Texas Yale Capital Corp increased its CME Group (CME) stake by 84% in Q2 2026, buying an estimated $1.43M and bringing the position to 11,316 shares worth $2.5M. The position accounts for 0.05% of the portfolio, ranked #184.

Texas Yale Capital Corp first reported a position in CME in Q3 2022 and has held it in 16 quarters since. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Texas Yale Capital Corp held 11,316 shares of CME Group worth $2.5M as of Q2 2026.
  • Texas Yale Capital Corp bought 5,180 CME Group shares in Q2 2026, an estimated $1.43M.
  • CME Group made up 0.05% of Texas Yale Capital Corp's portfolio in Q2 2026, its #184 holding.
  • Texas Yale Capital Corp first reported a position in CME Group in Q3 2022 and has held it in 16 quarters since.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.